| 发明名称 |
COMBINATION THERAPY COMPRISING SGLT INHIBITOR AND DPP4 INHIBITOR |
| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide an agent that can effectively increase in-blood active GLP-1 level in a patient. <P>SOLUTION: A combination therapy comprises a DPP4 inhibitor and an SGLT inhibitor. As the SGLT inhibitor, for example, a compound of the formula is used. The combination leads to increase plasma GLP-1 level and the combination is useful for prevention or treatment of conditions such as diabetes and diseases related to diabetes. <P>COPYRIGHT: (C)2013,JPO&INPIT |
| 申请公布号 |
JP2013091654(A) |
申请公布日期 |
2013.05.16 |
| 申请号 |
JP20120284625 |
申请日期 |
2012.12.27 |
| 申请人 |
MITSUBISHI TANABE PHARMA CORP |
发明人 |
UEDA KIICHIRO;ARAKAWA KENJI;MATSUSHITA YASUAKI |
| 分类号 |
A61K45/06;A61K31/496;A61K31/5377;A61K31/7042;A61K31/7056;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P9/10;A61P9/12;A61P13/12;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P27/12 |
主分类号 |
A61K45/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
